|
1
|
Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar
SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez
GA, et al: POEMS syndrome: Definitions and long-term outcome.
Blood. 101:2496–2506. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dispenzier A: POEMS syndrome: 2011 update
on diagnosis, risk-stratification and management. Am J Hematol.
86:592–601. 2011.
|
|
3
|
Sanada S, Ookawara S, Karube H, Shindo T,
Goto T, Nakamichi T, Saito M, Matsubara M and Suzuki M: Marked
recovery of severe renal lesions in POEMS syndrome with high-dose
melphalan therapy supported by autologous blood stem cell
transplantation. Am J Kidney Dis. 47:672–679. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakamoto Y, Imai H, Yasuda T, Wakui H and
Miura AB: A spectrum of clinicopathological features of nephropathy
associated with POEMS syndrome. Nephrol Dial Transplant.
14:2370–2378. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Watanabe O, Arimura K, Kitajima I, Osame M
and Maruyama I: Greatly raised vascular endothelial growth factor
(VEGF) in POEMS syndrome. Lancet. 347:7021996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh D, Wadhwa J, Kumar L, Raina V,
Agarwal A and Kochupillai V: POEMS syndrome: Experience with
fourteen cases. Leuk Lymphoma. 44:1749–1752. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Soubrier MJ, Dubost JJ and Sauvezie BJ:
POEMS syndrome: A study of 25 cases and a review of the literature.
French Study Group on POEMS syndrome. Am J Med. 97:543–553. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Zhou DB, Huang Z, Jiao L, Duan MH,
Zhang W, Zhao YQ and Shen T: Clinical characteristics and long-term
outcome of patients with POEMS syndrome in China. Ann Hematol.
90:819–826. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kulkarni GB, Mahadevan A, Taly AB, Yasha
TC, Seshagiri KS, Nalini A, Satishchandra P, Veerendrakumar M and
Shankar SK: Clinicopathological profile of polyneuropathy,
organomegaly, endocrinopathy, M protein and skin changes (POEMS)
syndrome. J Clin Neurosci. 18:356–360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Plata Bello J and Garcia-Marin V: POEMS
syndrome (polyneuropathy, organomegaly, endocrinopathy, multiple
myeloma and skin changes) with cranial vault plasmocytoma and the
role of surgery in its management: A case report. J Med Case Rep.
7:2452013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee FY and Chiu HC: POEMS syndrome with
calciphylaxis: A case report. Acta Derm Venereol. 91:96–97. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dispenzieri A: POEMS syndrome: 2014 update
on diagnosis, risk-stratification, and management. Am J Hematol.
89:214–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakamura Y, Nishimura M, Terano T,
McNamara KM, Sasano H, Kurosu A and Joh K: A patient with POEMS
syndrome: The pathology of glomerular microangiopathy. Tohoku J Exp
Med. 231:229–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaya P, Alemdaroğlu I, Yilmaz Ö, Karaduman
A and Topaloğlu H: Effect of muscle weakness distribution on
balance in neuromuscular disease. Pediatr Int. 57:92–97. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Devine MS, Kiernan MC, Heggie S, McCombe
PA and Henderson RD: Study of motor asymmetry in ALS indicates an
effect of limb dominance on onset and spread of weakness and an
important role for upper motor neurons. Amyotroph Lateral Scler
Frontotemporal Degener. 15:481–487. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuo DC, Bilal S and Koller P: Asymmetric
weakness and west nile virus infection. J Emerg Med. 49:274–276.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iolascon G, de Sire A, Calafiore D,
Moretti A, Gimigliano R and Gimigliano F: Hypovitaminosis D is
associated with a reduction in upper and lower limb muscle strength
and physical performance in post-menopausal women: A retrospective
study. Aging Clin Exp Res. 27 Suppl 1:S23–S30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dispenzieri A: POEMS Syndrome: 2014 update
on diagnosis, risk-stratification and management. Am J Hematol.
89:213–223. 2014. View Article : Google Scholar
|
|
19
|
Bardwick NJ, Zvaifler GN, Gill GN, Newman
D, Greenway G and Resnick DL: Plasma cell dyscrasia with
polyneuropathy, organomegaly, endocrinopathy, M protein, and skin
changes: The POEMS syndrome. Report on two cases and a review of
the literature. Medicine (Baltimore). 59:311–322. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rose C, Zandecki M, Copin MC, Gosset P,
Labalette M, Hatron PY, Jauberteau MO, Devulder B, Bauters F and
Facon T: POEMS syndrome: Report on six patients with unusual
clinical signs, elevated levels of cytokines, macrophage
involvement and chromosomal aberrations of bone marrow plasma
cells. Leukemia. 11:1318–1323. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hitoshi S, Suzuki K and Sakuta M: Elevated
serum interleukin-6 in POEMS syndrome reflects the activity of the
disease. Intern Med. 33:583–587. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Soubrier M, Sauron C, Souweine B, Larroche
C, Wechsler B, Guillevin L, Piette JC, Rousset H and Deteix P:
Growth factors and proinflammatory cytokines in the renal
involvement of POEMS syndrome. Am J Kidney Dis. 34:633–638. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tokashiki T, Hashiguchi T, Arimura K,
Eiraku N, Maruyama I and Osame M: Predictive value of serial
platelet count and VEGF determination for the management of DIC in
the Crow-Fukase (POEMS) syndrome. Intern Med. 42:1240–1243. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Niimi H, Arimura K, Jonosono M, Hashiguchi
T, Kawabata M, Osame M and Kitajima I: VEGF is causative for
pulmonary hypertension in a patient with Crow-Fukase (POEMS)
syndrome. Intern Med. 39:1101–1104. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dispenzieri A: How I treat POEMS syndrome.
Blood. 119:5650–5658. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kawano Y, Nakama T, Hata H, Kimura E,
Maruyoshi N, Uchino M and Mitsuya H: Successful treatment with
rituximab and thalidomide of POEMS syndrome associated with
Waldenstrom macroglobulinemia. J Neurol Sci. 297:101–104. 2012.
View Article : Google Scholar
|
|
27
|
Ohwada C, Nakaseko C, Sakai S, Takeda Y,
Abe D, Takeuchi M, Sakaida E, Masuda S, Shimizu N, Cho R, et al:
Successful combination treatment with bevacizumab, thalidomide and
autologous PBSC for severe POEMS syndrome. Bone Marrow Transplant.
43:739–740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kotani Y, Ito M, Abumi K, Yasui K and
Minami A: Neurological recovery from pentaplegia after resection
for sacral plasmacytoma presenting with POEMS syndrome. J Neurosurg
Spine. 10:324–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Allam JS, Kennedy CC, Aksamit TR and
Dispenzieri A: Pulmonary manifestations in patients with POEMS
syndrome: A retrospective review of 137 patients. Chest.
133:969–974. 2008. View Article : Google Scholar : PubMed/NCBI
|
